Stock Price Movement and Market Context
On 21 Nov 2025, National Peroxide's share price touched Rs.550, setting both a 52-week and all-time low. Despite this, the stock outperformed its sector by 0.96% on the day, showing a modest gain following two consecutive days of decline. However, the stock remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a sustained bearish trend over multiple time frames.
In contrast, the broader market index, Sensex, opened lower by 285.28 points and was trading at 85,243.02, down 0.46%. The Sensex remains close to its 52-week high of 85,801.70, just 0.66% away, and is trading above its 50-day moving average, which itself is positioned above the 200-day moving average, signalling a generally bullish market environment. This divergence highlights the relative underperformance of National Peroxide compared to the broader market.
Long-Term Performance and Valuation Trends
Over the past year, National Peroxide's stock has recorded a return of -32.74%, significantly lagging behind the Sensex's 10.48% gain during the same period. The stock's 52-week high was Rs.907.30, underscoring the extent of the decline from its peak. This underperformance extends beyond the last year, with the stock also trailing the BSE500 index over the last three years, one year, and three months, indicating persistent challenges in maintaining shareholder value.
Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!
- - Sustainable profitability reached
- - Post-turnaround strength
- - Comeback story unfolding
Financial Health and Profitability Indicators
National Peroxide's financial metrics reveal areas of concern. The company has experienced a compound annual growth rate (CAGR) of -135.58% in operating profits over the last five years, indicating a contraction in core earnings. The average EBIT to interest coverage ratio stands at a low 0.14, suggesting limited capacity to comfortably service debt obligations.
Return on equity (ROE) averages at 1.90%, reflecting modest profitability relative to shareholders’ funds. The latest six-month profit after tax (PAT) was Rs.1.28 crore, showing a decline of 77.78% compared to the previous period. Additionally, non-operating income for the quarter accounted for 263.49% of profit before tax (PBT), highlighting a reliance on income sources outside the company’s primary operations.
Risk Factors and Valuation Concerns
The stock is considered risky relative to its historical valuation levels. Over the past year, profits have fallen by 113%, compounding the negative return of 32.74% in share price. This combination of declining profitability and share price depreciation points to challenges in both operational and market performance.
National Peroxide's underperformance is evident not only in the short term but also over longer horizons, with returns trailing key benchmarks such as the BSE500. This trend underscores the difficulties faced by the company in reversing its financial trajectory.
Holding National Peroxide from Commodity Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Shareholding and Sector Position
National Peroxide operates within the commodity chemicals industry, a sector characterised by cyclical demand and sensitivity to raw material prices. The majority shareholding is held by promoters, which typically indicates concentrated ownership and potential influence over corporate decisions.
Despite the sector's inherent volatility, National Peroxide's recent performance contrasts with broader market trends, as the Sensex maintains a bullish stance while the stock remains under pressure.
Summary of Current Situation
The stock's fall to Rs.550 marks a significant low point for National Peroxide, reflecting a combination of subdued financial results, weak profitability metrics, and valuation pressures. While the broader market environment shows resilience, the company’s share price and earnings have not aligned with these positive trends.
Trading below all major moving averages and with a history of declining operating profits, National Peroxide faces a challenging landscape. The reliance on non-operating income to bolster profitability further emphasises the difficulties in generating consistent core earnings.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
